{
    "GOLD_15": {
        "reading": {
            "text": [],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {}
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_31": {
        "reading": {
            "text": [
                "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners",
                "sosei-heptares-hits-milestone-in-pfizer-collaboration"
            ],
            "viz": [
                "thromboembolic-events-don-t-appear-higher-in-vaccinated-population-ema-says"
            ]
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners": {
                                "key": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners",
                                "size": 167
                            },
                            "sosei-heptares-hits-milestone-in-pfizer-collaboration": {
                                "key": "sosei-heptares-hits-milestone-in-pfizer-collaboration",
                                "size": 166
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {
                    "astrazeneca": {
                        "key": "astrazeneca",
                        "children": {
                            "whyPositiveBox": {
                                "key": "whyPositiveBox",
                                "children": {
                                    "consistent": {
                                        "key": "consistent",
                                        "children": {
                                            "thromboembolic-events-don-t-appear-higher-in-vaccinated-population-ema-says": {
                                                "key": "thromboembolic-events-don-t-appear-higher-in-vaccinated-population-ema-says",
                                                "size": 167
                                            }
                                        }
                                    }
                                }
                            }
                        }
                    }
                }
            }
        }
    },
    "GOLD_14": {
        "reading": {
            "text": [],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {}
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_17": {
        "reading": {
            "text": [],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {}
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_12": {
        "reading": {
            "text": [
                "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners",
                "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids"
            ],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners": {
                                "key": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners",
                                "size": 105
                            },
                            "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {
                                "key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids",
                                "size": 99
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_18": {
        "reading": {
            "text": [
                "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain",
                "sosei-heptares-hits-milestone-in-pfizer-collaboration",
                "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days",
                "ec-signs-up-for-1-8-billion-additional-doses-of-comirnaty",
                "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids"
            ],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain": {
                                "key": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain",
                                "size": 105
                            },
                            "sosei-heptares-hits-milestone-in-pfizer-collaboration": {
                                "key": "sosei-heptares-hits-milestone-in-pfizer-collaboration",
                                "size": 92
                            },
                            "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days": {
                                "key": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days",
                                "size": 84
                            },
                            "ec-signs-up-for-1-8-billion-additional-doses-of-comirnaty": {
                                "key": "ec-signs-up-for-1-8-billion-additional-doses-of-comirnaty",
                                "size": 48
                            },
                            "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {
                                "key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids",
                                "size": 30
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_11": {
        "reading": {
            "text": [],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {}
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_9": {
        "reading": {
            "text": [],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {}
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_2": {
        "reading": {
            "text": [
                "coronavirus-vaccine-approved-for-use-in-children",
                "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales",
                "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners",
                "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents",
                "march-april-2021-pharmaceutical-m-a-round-up",
                "sosei-heptares-hits-milestone-in-pfizer-collaboration"
            ],
            "viz": [
                "eu-sues-vaccine-developer-while-usa-donates-excess-supplies"
            ]
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "coronavirus-vaccine-approved-for-use-in-children": {
                                "key": "coronavirus-vaccine-approved-for-use-in-children",
                                "size": 83
                            },
                            "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales": {
                                "key": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales",
                                "size": 36
                            },
                            "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners": {
                                "key": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners",
                                "size": 16
                            },
                            "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents": {
                                "key": "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents",
                                "size": 11
                            },
                            "march-april-2021-pharmaceutical-m-a-round-up": {
                                "key": "march-april-2021-pharmaceutical-m-a-round-up",
                                "size": 5
                            },
                            "sosei-heptares-hits-milestone-in-pfizer-collaboration": {
                                "key": "sosei-heptares-hits-milestone-in-pfizer-collaboration",
                                "size": 2
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {
                    "astrazeneca": {
                        "key": "astrazeneca",
                        "children": {
                            "whoBox": {
                                "key": "whoBox",
                                "children": {
                                    "consistent": {
                                        "key": "consistent",
                                        "children": {
                                            "eu-sues-vaccine-developer-while-usa-donates-excess-supplies": {
                                                "key": "eu-sues-vaccine-developer-while-usa-donates-excess-supplies",
                                                "size": 7
                                            }
                                        }
                                    }
                                }
                            }
                        }
                    }
                }
            }
        }
    },
    "GOLD_19": {
        "reading": {
            "text": [],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {}
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_4": {
        "reading": {
            "text": [
                "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales",
                "record-breaking-sales-of-24-8bn-by-2021-predicted-for-pfizer-biontech-s-vaccine",
                "trial-in-children-could-help-increase-vaccine-coverage",
                "vaccines-seem-effective-against-brazilian-variant"
            ],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales": {
                                "key": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales",
                                "size": 33
                            },
                            "record-breaking-sales-of-24-8bn-by-2021-predicted-for-pfizer-biontech-s-vaccine": {
                                "key": "record-breaking-sales-of-24-8bn-by-2021-predicted-for-pfizer-biontech-s-vaccine",
                                "size": 4
                            },
                            "trial-in-children-could-help-increase-vaccine-coverage": {
                                "key": "trial-in-children-could-help-increase-vaccine-coverage",
                                "size": 3
                            },
                            "vaccines-seem-effective-against-brazilian-variant": {
                                "key": "vaccines-seem-effective-against-brazilian-variant",
                                "size": 3
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_3": {
        "reading": {
            "text": [],
            "viz": [
                "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots"
            ]
        },
        "mind_map": {
            "text": {
                "nodes": {}
            },
            "viz": {
                "nodes": {
                    "astrazeneca": {
                        "key": "astrazeneca",
                        "children": {
                            "whyNegativeBox": {
                                "key": "whyNegativeBox",
                                "children": {
                                    "consistent": {
                                        "key": "consistent",
                                        "children": {
                                            "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots": {
                                                "key": "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots",
                                                "size": 58
                                            }
                                        }
                                    }
                                }
                            }
                        }
                    }
                }
            }
        }
    },
    "GOLD_24": {
        "reading": {
            "text": [
                "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days",
                "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain",
                "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents"
            ],
            "viz": [
                "full-program-for-astrazeneca-at-asco-2021",
                "eu-sues-vaccine-developer-while-usa-donates-excess-supplies",
                "full-program-for-astrazeneca-at-asco-2021",
                "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots"
            ]
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days": {
                                "key": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days",
                                "size": 51
                            },
                            "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain": {
                                "key": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain",
                                "size": 39
                            },
                            "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents": {
                                "key": "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents",
                                "size": 39
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {
                    "astrazeneca": {
                        "key": "astrazeneca",
                        "children": {
                            "whatTopicBox": {
                                "key": "whatTopicBox",
                                "children": {
                                    "consistent": {
                                        "key": "consistent",
                                        "children": {
                                            "full-program-for-astrazeneca-at-asco-2021": {
                                                "key": "full-program-for-astrazeneca-at-asco-2021",
                                                "size": 8
                                            }
                                        }
                                    }
                                }
                            },
                            "whatActionBox": {
                                "key": "whatActionBox",
                                "children": {
                                    "consistent": {
                                        "key": "consistent",
                                        "children": {
                                            "eu-sues-vaccine-developer-while-usa-donates-excess-supplies": {
                                                "key": "eu-sues-vaccine-developer-while-usa-donates-excess-supplies",
                                                "size": 5
                                            },
                                            "full-program-for-astrazeneca-at-asco-2021": {
                                                "key": "full-program-for-astrazeneca-at-asco-2021",
                                                "size": 4
                                            }
                                        }
                                    }
                                }
                            },
                            "whyPositiveBox": {
                                "key": "whyPositiveBox",
                                "children": {
                                    "consistent": {
                                        "key": "consistent",
                                        "children": {
                                            "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots": {
                                                "key": "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots",
                                                "size": 1
                                            }
                                        }
                                    }
                                }
                            }
                        }
                    }
                }
            }
        }
    },
    "GOLD_28": {
        "reading": {
            "text": [
                "pfizer-and-biontech-initiate-fda-rolling-bla-submission-for-their-covid-19-vaccine",
                "coronavirus-vaccine-approved-for-use-in-children",
                "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales",
                "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids",
                "latest-pfizer-biontech-results-offer-youthful-optimism",
                "trial-in-children-could-help-increase-vaccine-coverage"
            ],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "pfizer-and-biontech-initiate-fda-rolling-bla-submission-for-their-covid-19-vaccine": {
                                "key": "pfizer-and-biontech-initiate-fda-rolling-bla-submission-for-their-covid-19-vaccine",
                                "size": 41
                            },
                            "coronavirus-vaccine-approved-for-use-in-children": {
                                "key": "coronavirus-vaccine-approved-for-use-in-children",
                                "size": 32
                            },
                            "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales": {
                                "key": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales",
                                "size": 23
                            },
                            "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {
                                "key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids",
                                "size": 21
                            },
                            "latest-pfizer-biontech-results-offer-youthful-optimism": {
                                "key": "latest-pfizer-biontech-results-offer-youthful-optimism",
                                "size": 19
                            },
                            "trial-in-children-could-help-increase-vaccine-coverage": {
                                "key": "trial-in-children-could-help-increase-vaccine-coverage",
                                "size": 17
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_16": {
        "reading": {
            "text": [
                "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain",
                "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days",
                "pfizer-takes-aim-at-coronavirus-and-vaccines-market",
                "vaccines-seem-effective-against-brazilian-variant",
                "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids"
            ],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain": {
                                "key": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain",
                                "size": 33
                            },
                            "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days": {
                                "key": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days",
                                "size": 29
                            },
                            "pfizer-takes-aim-at-coronavirus-and-vaccines-market": {
                                "key": "pfizer-takes-aim-at-coronavirus-and-vaccines-market",
                                "size": 20
                            },
                            "vaccines-seem-effective-against-brazilian-variant": {
                                "key": "vaccines-seem-effective-against-brazilian-variant",
                                "size": 19
                            },
                            "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {
                                "key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids",
                                "size": 11
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_20": {
        "reading": {
            "text": [
                "latest-pfizer-biontech-results-offer-youthful-optimism",
                "pfizer-expands-anti-infectives-pipeline-with-acquisition"
            ],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "latest-pfizer-biontech-results-offer-youthful-optimism": {
                                "key": "latest-pfizer-biontech-results-offer-youthful-optimism",
                                "size": 17
                            },
                            "pfizer-expands-anti-infectives-pipeline-with-acquisition": {
                                "key": "pfizer-expands-anti-infectives-pipeline-with-acquisition",
                                "size": 4
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {}
            }
        }
    },
    "GOLD_30": {
        "reading": {
            "text": [
                "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids",
                "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain",
                "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days",
                "pfizer-takes-aim-at-coronavirus-and-vaccines-market"
            ],
            "viz": []
        },
        "mind_map": {
            "text": {
                "nodes": {
                    "pfizer": {
                        "key": "pfizer",
                        "children": {
                            "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {
                                "key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids",
                                "size": 16
                            },
                            "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain": {
                                "key": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain",
                                "size": 13
                            },
                            "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days": {
                                "key": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days",
                                "size": 12
                            },
                            "pfizer-takes-aim-at-coronavirus-and-vaccines-market": {
                                "key": "pfizer-takes-aim-at-coronavirus-and-vaccines-market",
                                "size": 7
                            }
                        }
                    }
                }
            },
            "viz": {
                "nodes": {}
            }
        }
    }
}